Search for: "Eli Lilly "
Results 301 - 320
of 2,147
Sort by Relevance
|
Sort by Date
17 Jan 2019, 11:09 pm
In many circumstances, she had to make a decision because the law required it but it was not necessarily the best thing for the family.Inevitably there was some discussion about the implications of Actavis v Eli Lilly [2017] UKSC 48. [read post]
16 Jan 2019, 9:42 pm
Eli Lilly. [read post]
11 Jan 2019, 4:00 am
In the UK, the Supreme Court in 2017 released its decision in Actavis UK Ltd v Eli Lilly & Co [2017] UKSC 48 which allowed for variants in claim construction. [read post]
29 Dec 2018, 6:30 am
Sara MoranApplying the so-called ‘Actavis Questions’ (further to the Supreme Court decision in Actavis v Eli Lilly), the Court of Appeal reached a different conclusion from the Patents Court on the issue of infringement. [read post]
29 Dec 2018, 2:17 am
| Book Review: Kerly’s Law of Trade Marks and Trade Names | Thursday Thingies | Around the IP BlogsNever Too Late 204 [Week ending 28 Oct]Court of Appeal reaffirms UK as SEP litigation hotspot in upholding Birss J in Unwired Planet | Much Ado About FRAND: What you need to know about today's Court of Appeal Unwired Planet decision | AIPPI UK Rapid Response Event: Unwired Planet v Huawei - 13 November at 6PM | Lord Kitchin applies the "markedly different" infringement… [read post]
21 Dec 2018, 9:14 am
This arose in the context of the drug Tadalafil which treats male erectile dysfunction and has a European patent owned by ICOS and exclusively licensed to Eli Lilly. [read post]
20 Dec 2018, 6:09 am
Before actually dealing with Teva, he walked the audience through Medeva, Actavis v Sanofi (C-443/12) as well as Eli Lilly v HGS (C-493/12) (both judgments issued on 12 December 2013). [read post]
19 Dec 2018, 9:49 am
| Book Review: Kerly’s Law of Trade Marks and Trade Names | Thursday Thingies | Around the IP BlogsNever Too Late 204 [Week ending 28 Oct] Court of Appeal reaffirms UK as SEP litigation hotspot in upholding Birss J in Unwired Planet | Much Ado About FRAND: What you need to know about today's Court of Appeal Unwired Planet decision | AIPPI UK Rapid Response Event: Unwired Planet v Huawei - 13 November at 6PM | Lord Kitchin applies the "markedly different" infringement… [read post]
14 Dec 2018, 7:55 pm
Sara MoranThe Court of Appeal overturned the Patent Court’s first instance decision concerning the validity of one of ICOS’s patents (licensed to Eli Lilly) covering a 1 to 5mg dosage form of tadalafil (Cialis®) for oral administration up to a maximum of 5mg per day for the treatment of sexual dysfunction. [read post]
11 Dec 2018, 5:50 am
First panel discussion: Pros and Cons of Different Patent Litigation Systems in Europe The first panel was composed of Ivan Burnside (Eli Lilly), George Moore (Mylan) and Clemens Heusch (Nokia) giving their personal in-house counsel perspectives on different patent litigation systems based on their experience with parallel cases in many European jurisdictions.One of the key points to emerge from this discussion was that judges must be educated by appropriate experts in the… [read post]
11 Dec 2018, 4:55 am
| Book Review: Kerly’s Law of Trade Marks and Trade Names | Thursday Thingies | Around the IP BlogsNever Too Late 204 [Week ending 28 Oct] Court of Appeal reaffirms UK as SEP litigation hotspot in upholding Birss J in Unwired Planet | Much Ado About FRAND: What you need to know about today's Court of Appeal Unwired Planet decision | AIPPI UK Rapid Response Event: Unwired Planet v Huawei - 13 November at 6PM | Lord Kitchin applies the "markedly different" infringement… [read post]
7 Dec 2018, 2:23 pm
”AbbVie, 764 F.3d at 1372 (citing Eli Lilly & Co. v. [read post]
7 Dec 2018, 3:00 am
According to the study, they include GE, Intel, Pfizer, Allstate, Medtronic, Eli Lilly, Southwest Airlnes, AEP, Ingersoll Rand, Praxair, Entergy, Clorox, NiSource & Dentsply Sirona. [read post]
27 Nov 2018, 3:19 am
Image Credits: In NYCPREVIOUSLY ON NEVER TOO LATENever Too Late 204 [Week ending 28 Oct] Court of Appeal reaffirms UK as SEP litigation hotspot in upholding Birss J in Unwired Planet | Much Ado About FRAND: What you need to know about today's Court of Appeal Unwired Planet decision | AIPPI UK Rapid Response Event: Unwired Planet v Huawei - 13 November at 6PM | Lord Kitchin applies the "markedly different" infringement approach in Actavis v Eli Lilly in… [read post]
21 Nov 2018, 12:04 pm
We begin this week with an update on the pemetrexed (Alimta) Italian patent case between Fresenius Kabi and Eli Lilly.Pemetrexed disodium at the Court of MilanLast year, IPKat blogged about the Court of Milan's decision in the pemetrexed (Alimta) patent case (Court of Milan, 12 September 2017, urgent proceedings between Fresenius Kabi and Eli Lilly).That decision has now been fully reversed by a panel of three judges of the same Court of… [read post]
21 Nov 2018, 12:00 am
Alexa von Uexküll and Oswin RidderbuschOver the past few years the pan-European and parallel national patent litigation based on Eli Lilly’s pemetrexed patent has attracted considerable attention, as it has resulted in a number of diverse land mark decisions in relation to the doctrine of equivalence, as evidenced by the various posts in this blog. [read post]
19 Nov 2018, 4:28 pm
Uruguay, Eli Lilly v. [read post]
18 Nov 2018, 7:39 am
In her comment Lord Kitchin applies the "markedly different" infringement approach in Actavis v Eli Lilly in Icescape v Ice-World, InternKat Rose analyses this recent case to determine whether Lord Kitchin approached any of the unresolved issues left in the Actavis v Eli Lilly case.CopyrightLast year The IPKat reported on two new important referrals to the Court of Justice of the European Union (CJEU) from Germany. [read post]
1 Nov 2018, 6:26 am
The warning applies to the class of SGLT2 inhibitors, specifically, Johnson & Johnson’s Invokana (canagliflozin), AstraZeneca Plc’s Farxiga (dapagliflozin), and Eli Lilly & Co. [read post]
24 Oct 2018, 3:49 am
Since the landmark UK Supreme Court decision in Actavis v Eli Lilly ([2017] UKSC 48), judges of the lower courts have voiced the need for clarification from the Supreme Court. [read post]
